DrugPatentWatch Database Preview
Foldrx Pharms Company Profile
Email this page to a colleague
What is the competitive landscape for FOLDRX PHARMS, and what generic alternatives to FOLDRX PHARMS drugs are available?
FOLDRX PHARMS has two approved drugs.
There are five US patents protecting FOLDRX PHARMS drugs.
There are forty-eight patent family members on FOLDRX PHARMS drugs in twenty-three countries and fourteen supplementary protection certificates in thirteen countries.
Summary for Foldrx Pharms
| International Patents: | 48 |
| US Patents: | 5 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Foldrx Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foldrx Pharms | VYNDAMAX | tafamidis | CAPSULE;ORAL | 212161-001 | May 3, 2019 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | |||||
| Foldrx Pharms | VYNDAMAX | tafamidis | CAPSULE;ORAL | 212161-001 | May 3, 2019 | RX | Yes | Yes | 7,214,696 | ⤷ Try it Free | ⤷ Try it Free | ||||
| Foldrx Pharms | VYNDAQEL | tafamidis meglumine | CAPSULE;ORAL | 211996-001 | May 3, 2019 | RX | Yes | Yes | 8,653,119 | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Foldrx Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Germany | 122012000007 | ⤷ Try it Free |
| Spain | 2312857 | ⤷ Try it Free |
| European Patent Office | 1587821 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Foldrx Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1587821 | C 2012 004 | Romania | ⤷ Try it Free | PRODUCT NAME: TAFAMIDISMEGLUMINA; NATIONAL AUTHORISATION NUMBER: EU/1/11/717/001; DATE OF NATIONAL AUTHORISATION: 20111116; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/11/717/001; DATE OF FIRST AUTHORISATION IN EEA: 20111116 |
| 1587821 | CA 2012 00006 | Denmark | ⤷ Try it Free | |
| 1587821 | 91935 | Luxembourg | ⤷ Try it Free | 91935, EXPIRES: 20261116 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
